Search results
Results from the WOW.Com Content Network
A choke is designed to alter or shape the distribution of the shot as it leaves the firearm. For shooting most game birds and clay pigeons, a desirable pattern is one that is as large as possible while being dense enough to ensure multiple hits on the target, at a particular range. The choke should be tailored to the range and size of the targets.
The Beretta 1301 is a gas-operated semi-automatic shotgun produced by Beretta, and imported by Beretta USA in the United States. [1] The firearm has two distinct models: The 1301 Tactical is intended for tactical self-defense and law enforcement applications whereas the 1301 Competition is designed for practical shooting sports such as Multigun or IPSC Shotgun.
The Beretta 93R is an Italian selective-fire machine pistol, designed and manufactured by Beretta in the late 1970s for police and military use, that is derived from their semi-automatic Beretta 92. The "R" stands for Raffica , which is Italian for "volley", "flurry", or "burst" (sometimes spoken "R" as "Rapid" in English).
The Beretta 950 is a semi-automatic pistol designed and manufactured by Beretta since 1952. It builds on a long line of small and compact pocket pistols manufactured by Beretta for self-defense . It was intended to be a very simple and reliable pocket pistol.
The AOL.com video experience serves up the best video content from AOL and around the web, curating informative and entertaining snackable videos.
The Xtrema2 was released in mid-2004, to answer the call from hunters and target shooters for a complete do-all shotgun. Beretta's goal was to produce a shotgun that could reliably fire 2¾” loaded with light target loads all the way through the 3½” super magnum round without any modification or settings to be dealt with.
The U.S. Federal Emergency Management Agency - whose mission is to help people before, during and after disasters - fired an employee who advised her survivor assistance team in Florida to not go ...
A leaked video of UnitedHealth CEO Andrew Witty defending claim denials after Brian Thompson’s murder has sparked backlash. Critics argue the policy contributes to medical bankruptcies and lives ...